PDE4A and pulmonary fibrosis: In this regard, PDE4 inhibition reduces fibrotic markers, activation of lung fibroblasts and EMT (Milara et al. 2014a, b; Vecchio et al. 2013) as well as lung fibrosis in an animal model of intratracheal bleomycin (Cortijo et al. 2009).